首页> 外文期刊>Genetic Testing >Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case-Control Study with Breast Cancer
【24h】

Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case-Control Study with Breast Cancer

机译:乳腺癌病例对照研究中编码Toll样受体-2,-3,-4和-9的基因中的单核苷酸多态性

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Genetic susceptibility to cancer is multifactorial, and it is known that impairment of the immune system could contribute to risk for getting cancer. Aim of the Study: Single-nucleotide polymorphisms (SNPs) of Toll-like receptor (TLR) 2, TLR3, TLR4, and TLR9 genes, which are important for innate immunity, were analyzed for the association with breast cancer. Methods: The SNPs comprised TLR2 (c.597T>C), TLR2 (c.1350T>C), TLR3 (c.1377C>T), TLR4 (c.896A>G), and TLR9 (c.1635A>G). The allelic and genotypic frequencies of these TLR SNPs were compared between patients (n = 130) and controls (n = 101) in a case-control study from Croatia. Results: TLR SNPs were not significantly different. From the population genetics viewpoint, we found that a hypomorphic variant of TLR4 (p.Asp299Gly) allele has no specific allelic frequency (8.4%) in the Croatian population (n = 496) compared to other Caucasians (6.5-10%). Conclusion: These results suggest that polymorphisms in tested TLR genes are not likely to be associated with increased risk for developing breast cancer.
机译:背景:癌症的遗传易感性是多因素的,众所周知,免疫系统受损可能会增加患癌症的风险。研究的目的:分析了与先天免疫有关的Toll样受体(TLR)2,TLR3,TLR4和TLR9基因的单核苷酸多态性(SNPs)与乳腺癌的关系。方法:SNPs包括TLR2(c.597T> C),TLR2(c.1350T> C),TLR3(c.1377C> T),TLR4(c.896A> G)和TLR9(c.1635A> G)。 。在克罗地亚的一项病例对照研究中,比较了这些TLR SNP的等位基因和基因型频率在患者(n = 130)和对照(n = 101)之间。结果:TLR SNPs没有显着差异。从种群遗传学的角度来看,与其他白种人(6.5-10%)相比,TLR4(p.Asp299Gly)等位基因的亚型变异在克罗地亚人群(n = 496)中没有特定的等位基因频率(8.4%)。结论:这些结果表明,测试的TLR基因中的多态性不太可能与患乳腺癌的风险增加相关。

著录项

  • 来源
    《Genetic Testing》 |2009年第6期|729-734|共6页
  • 作者单位

    Faculty of Dentistry, Institute for Oral Biology, University of Oslo, Oslo, Norway;

    Division of Molecular Medicine Laboratory of Molecular Oncology Ruder Boskovic Institute Bijenicka cesta 54 Zagreb 10 000 Croatia;

    Faculty of Dentistry, Institute for Oral Biology, University of Oslo, Oslo, Norway Departments of Medical Oncology, Clinical Hospital Center 'Zagreb,' University of Zagreb, Zagreb, Croatia Departments of Oncology, Clinical Hospital Center 'Zagreb,' University of Zagreb, Zagreb, Croatia;

    Division of Molecular Medicine, Laboratory of Molecular Oncology, Rudjer Boskovic Institute, Zagreb, Croatia;

    Departments of Medical Oncology, Clinical Hospital Center 'Zagreb,' University of Zagreb, Zagreb, Croatia;

    Faculty of Dentistry, Institute for Oral Biology, University of Oslo, Oslo, Norway;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:21:33

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号